Utah Medical Products (NASDAQ:UTMD) stock recently broke above its 200-day moving average, trading as high as $68.71. Despite this technical breakout, analysts maintain a “Sell” rating for the stock. However, the company demonstrates solid fundamentals with a 29.3% net margin, a market cap of $217M, and a P/E of 19.49, along with a declared quarterly dividend.
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
Utah Medical Products (NASDAQ:UTMD) Stock Price Passes Above 200 Day Moving Average - What's Next?
Utah Medical Products (NASDAQ:UTMD) stock recently broke above its 200-day moving average, trading as high as $68.71. Despite this technical breakout, analysts maintain a “Sell” rating for the stock. However, the company demonstrates solid fundamentals with a 29.3% net margin, a market cap of $217M, and a P/E of 19.49, along with a declared quarterly dividend.